Manufacturing

Standard immunotherapy often fails when cancer cells stop expressing a single target protein, a biological loophole that the new trispecific design aims to close by targeting CD19, CD20, and CD22. This experimental breakthrough, emerging from a phase I clinical trial at The Ohio State University

Evidence from German manufacturing facilities suggests that electrification can effectively eliminate direct emissions even if it temporarily increases purchased energy figures. This shift represents a fundamental transformation in how life sciences companies approach their environmental footprint

The development of the p(BA-V4D4) copolymer provides a balance of softness for stress absorption and strength to maintain structural integrity during rapid ion movement. While most consumers associate battery degradation with a mysterious chemical expiration, the primary driver of failure in modern

Nanoscale carriers act as protective transportation for biologics and vaccines, ensuring the therapeutic message reaches its destination without being degraded by the body's immune response. This fundamental breakthrough represents a monumental shift in how the University of Waterloo’s Faculty of

The high cost of exogenous growth factors like BMP-2 remains a major financial barrier to the commercial production of living, engineered bone substitutes. For decades, the reliance on these expensive proteins has restricted high-end tissue engineering to academic research, but the landscape is

Engineering stable microbial cell factories requires genetic tools that function reliably when integrated into the chromosome rather than relying on high-copy plasmids. This foundational principle guided a recent high-impact collaboration between scientific teams in Argentina and Spain, who sought